Minimed Posts 61% Rise in 2nd-Quarter Profit
- Share via
Minimed Inc. posted a 61% increase in its second-quarter net income on a 28% jump in revenues.
For the quarter that ended June 27, Minimed earned $1.5 million, compared with a $932,000 profit a year earlier. Sales for the latest quarter rose to $17.0 million, compared with $13.3 million last year.
The Sylmar-based concern makes infusion systems used in treating diabetes.
For the six months, Minimed posted a profit of $2.6 million, compared with $1.6 million a year ago. Six-month sales rose 23% to $32.3 million, up from $26.5 million a year earlier.
Commenting on the results, Minimed CEO Alfred E. Mann said that the worldwide market for insulin pumps remains largely untapped, with significant potential for growth.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
